4571.T - NANO MRNA Co.,Ltd.
NEXT EARNINGS:
May 20, 2026
Price:
--
--
Market Cap:
13.25B
Volume:
2,767,600
Avg Volume:
742,461
52 Week Range:
113-254
Sector:
Healthcare
Industry:
Biotechnology
Beta:
0.16
Last Dividend:
$N/A
Exchange:
JPX
Country:
JP
Employees:
18
IPO Date:
2008-03-05
EPS (TTM):
-11.85
P/E Ratio:
-12.16
Revenue (TTM):
108.52M
Total Assets:
4.00B
Total Debt:
540.24M
Cash & Equiv:
1.71B
Rev Growth (5Y):
-27.8%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-29.8%
Debt/Equity:
0.20
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-13 | $-2.85 | — | — | $89.8M | — | — |
| 2025-11-14 | $-3.36 | — | — | $33.4M | — | — |
| 2025-08-08 | $-2.85 | — | — | $7.7M | — | — |
| 2025-05-14 | $-3.40 | — | — | $25.4M | — | — |
| 2025-02-12 | $-1.09 | — | — | $76.0M | — | — |
| 2024-11-14 | $-5.14 | — | — | $7.0M | — | — |
| 2024-08-09 | $-2.22 | — | — | — | — | — |
| 2024-05-14 | $-0.60 | — | — | $31.2M | $32.0M | -2.5% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 108.52M | 135.51M | 202.19M | 264.03M | 313.26M | 552.97M | 496.73M | 259.10M | 218.69M | 243.34M | 675.80M | 472.20M |
| Net Income | (835.38M) | (780.00M) | (1.31B) | (1.88B) | (2.84B) | (2.01B) | (1.81B) | (5.42B) | (2.68B) | (2.54B) | (207.16M) | (1.11B) |
| EPS | -11.85 | -11.10 | -18.70 | -26.90 | -41.53 | -32.68 | -39.14 | -125.39 | -62.07 | -59.53 | -5.12 | -30.44 |
| Total Assets | 4.00B | 5.07B | 5.78B | 7.14B | 7.82B | 8.94B | 8.57B | 7.63B | 12.94B | 15.39B | 14.70B | 14.34B |
| Total Debt | 540.24M | 1.11B | 1.11B | 1.15B | 0 | 0 | 2.48B | 2.48B | 2.48B | 3.00B | 0 | 540.00M |
| Cash & Equivalents | 1.71B | 2.08B | 2.81B | 3.54B | 3.89B | 4.47B | 4.57B | 3.69B | 9.40B | 12.08B | 13.67B | 7.14B |
| Operating Cash Flow | (401.62M) | (585.08M) | (1.09B) | (1.75B) | (1.25B) | (1.14B) | (2.04B) | (4.93B) | (2.53B) | (1.97B) | (1.12B) | (1.09B) |
| Free Cash Flow | 0 | (585.08M) | (1.09B) | (1.76B) | (1.25B) | (1.14B) | (2.04B) | (4.99B) | (2.70B) | (2.06B) | (1.29B) | (1.11B) |
| FCF per Share | N/A | -8.33 | -15.51 | -25.15 | -18.27 | -18.52 | -44.25 | -115.55 | -62.69 | -48.34 | -31.82 | -30.44 |
| Book Value | 2.74B | 3.42B | 4.25B | 5.57B | 7.50B | 8.77B | 5.88B | 4.66B | 10.07B | 12.13B | 14.50B | 13.60B |
| Cash & ST Investments | 3.51B | 4.28B | 4.44B | 5.95B | 6.40B | 7.47B | 6.57B | 6.41B | 11.77B | 13.76B | 13.77B | 7.25B |
| ROC Equity | -0.30 | -0.23 | -0.31 | -0.34 | -0.38 | -0.23 | -0.31 | -1.16 | -0.27 | -0.21 | -0.01 | -0.08 |